262 related articles for article (PubMed ID: 10023900)
1. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
Maddison P; Newsom-Davis J; Mills KR; Souhami RL
Lancet; 1999 Jan; 353(9147):117-8. PubMed ID: 10023900
[No Abstract] [Full Text] [Related]
2. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
3. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
4. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
5. SOX1 autoantibodies: tumor markers in LEMS patients?
Lang B; Evoli A
Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
[No Abstract] [Full Text] [Related]
6. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
[No Abstract] [Full Text] [Related]
7. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
Sher E; Comola M; Nemni R; Canal N; Clementi F
Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
[No Abstract] [Full Text] [Related]
8. Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration.
Tanaka K; Motomura M; Nakao Y; Tanaka M; Tsuji S
Neurology; 1997 Sep; 49(3):895-6. PubMed ID: 9305368
[No Abstract] [Full Text] [Related]
9. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 1) The molecular structure of calcium channel and immunology].
Komai K; Iwasa K; Takamori M
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):678-84. PubMed ID: 9627477
[No Abstract] [Full Text] [Related]
10. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Titulaer MJ; Lang B; Verschuuren JJ
Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
[TBL] [Abstract][Full Text] [Related]
11. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome.
Hermitte L; Martin-Moutot N; Boucraut J; Barone R; Atlan-Gepner C; Seagar M; Pouget J; Kleisbauer JP; Couraud F; Vialettes B
J Clin Immunol; 2000 Jul; 20(4):287-93. PubMed ID: 10939716
[TBL] [Abstract][Full Text] [Related]
12. [Lambert-Eaton syndrome without calcium channel autoantibodies].
Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
[TBL] [Abstract][Full Text] [Related]
13. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
Wirtz PW; Lang B; Graus F; van den Maagdenberg AM; Saiz A; de Koning Gans PA; Twijnstra A; Verschuuren JJ
J Neuroimmunol; 2005 Jul; 164(1-2):161-5. PubMed ID: 15904978
[TBL] [Abstract][Full Text] [Related]
14. The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
Lang B; Waterman S; Pinto A; Jones D; Moss F; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Motomura M; Moll JW; Vincent A; Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():596-605. PubMed ID: 9668304
[No Abstract] [Full Text] [Related]
15. Anesthesia for an unsuspected Lambert-Eaton myasthenic syndrome with autoantibodies and occult small cell lung carcinoma.
Small S; Ali HH; Lennon VA; Brown RH; Carr DB; de Armendi A
Anesthesiology; 1992 Jan; 76(1):142-5. PubMed ID: 1309626
[No Abstract] [Full Text] [Related]
16. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
Takamori M; Takahashi M; Yasukawa Y; Iwasa K; Nemoto Y; Suenaga A; Nagataki S; Nakamura T
J Neurol Sci; 1995 Nov; 133(1-2):95-101. PubMed ID: 8583238
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
[TBL] [Abstract][Full Text] [Related]
18. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
[TBL] [Abstract][Full Text] [Related]
19. Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
Sher E; Carbone E; Clementi F
Ann N Y Acad Sci; 1993 Jun; 681():373-81. PubMed ID: 8395151
[No Abstract] [Full Text] [Related]
20. [Relationship between neuromuscular diseases and cancers].
Takamori M
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1841-51. PubMed ID: 10581772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
